Pfizer Submits Emergency Use Authorization Request for Oral Antiviral Paxlovid to FDA

On November 16 local time, Pfizer, Inc. announced that it had submitted an application to the U.S. Food and Drug Administration for emergency use authorization of its experimental oral antiviral drug PAXLOVID.

The advisory committee of the U.S. Food and Drug Administration plans to meet on November 30 to discuss the application. (CGTN Reporter Tao Xu)